# Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion

> **NCT02338466** · PHASE2 · WITHDRAWN · sponsor: **University Hospital Center of Martinique**

## Conditions studied

- Nervous System Disorders
- Cerebral Artery

## Interventions

- **DRUG:** rt-PA
- **DRUG:** tenecteplase

## Key facts

- **NCT ID:** NCT02338466
- **Lead sponsor:** University Hospital Center of Martinique
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-07
- **Primary completion:** 2018-07
- **Final completion:** 2018-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Departure of the principal investigator and lack of succession
- **Last updated:** 2018-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338466, "Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02338466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*